
Spanish Scientists Shrink Pancreatic Tumors in Mice
Researchers in Spain have eliminated pancreatic tumors in mice using a groundbreaking triple-drug combination. The approach tackles one of the deadliest cancers by preventing treatment resistance.
Find uplifting stories about heroes, innovations, and solutions
931 results for "pancreatic tumor"

Researchers in Spain have eliminated pancreatic tumors in mice using a groundbreaking triple-drug combination. The approach tackles one of the deadliest cancers by preventing treatment resistance.

A new triple therapy treatment completely eliminated pancreatic tumors in mice, offering hope for one of the deadliest cancers. The breakthrough could transform treatment for the 67,000 Americans diagnosed each year.

Scientists in Spain have developed a three-drug combination that completely eliminated pancreatic tumors in lab models for over 200 days without resistance. The breakthrough targets one of the deadliest cancers from multiple angles simultaneously.

A breakthrough pill for pancreatic cancer, the deadliest major cancer, shows stunning results in trials. Former Senator Ben Sasse's tumors shrank 76% after taking the experimental drug that could become the first targeted treatment for this disease.
Researchers in Spain have found a triple-drug combination that eliminates pancreatic tumors in mice without them returning. The breakthrough could eventually transform treatment for one of cancer's deadliest forms.

Spanish researchers have discovered a breakthrough triple-drug combination that completely eliminated pancreatic tumors in mice without significant side effects. The finding offers new hope for one of the deadliest cancers, which currently has a survival rate below 10 percent.

Researchers in Germany discovered how pancreatic cancer hides from the immune system and successfully shrank tumors by 94% in animal studies. The breakthrough could transform treatment for one of the deadliest cancers.

Former Senator Ben Sasse was given months to live after a stage 4 pancreatic cancer diagnosis, but an experimental pill has shrunk his tumors by 76% and nearly eliminated his pain. The breakthrough drug could double survival time for patients with this deadly disease.

Scientists in Spain eliminated pancreatic tumors in mice using a triple-drug therapy, with no cancer returning over 200 days. The breakthrough targets the deadliest form of pancreatic cancer and could reshape treatment if human trials succeed.

University of Pennsylvania researchers eliminated precancerous pancreatic cells in mice before they became tumors, nearly doubling survival time. It's the first proof that medical intervention can stop pancreatic cancer at its earliest stage.
Researchers at MD Anderson Cancer Center discovered a protein called DPY30 that helps pancreatic tumors hide from the immune system. Blocking this protein could make stubborn tumors respond to immunotherapy, offering fresh hope for patients with limited treatment options.

An experimental once-daily pill nearly doubled survival time for patients with advanced pancreatic cancer, offering hope for one of the deadliest forms of the disease. The breakthrough targets a mutation present in over 90% of pancreatic tumors that scientists have struggled to treat for four decades.

Researchers in Spain have completely eliminated pancreatic tumors in mice using a groundbreaking triple-drug therapy with no major side effects. The discovery brings fresh hope for treating one of the deadliest cancers, with human clinical trials potentially on the horizon.

Spanish scientists completely eliminated pancreatic tumors in mice using a three-drug combination, offering new hope for one of the world's deadliest cancers. The breakthrough targets a gene mutation found in over 90% of human cases.

Researchers discovered that pancreatic cancer cells depend on inflammation from damaged mitochondria to survive, and blocking this process kills tumors. The breakthrough could finally offer new treatment options for one of the deadliest cancers.

Scientists at Oregon Health & Science University discovered that stress nerves help pancreatic tumors grow, opening doors to potential new treatments. The breakthrough could transform how we fight one of the deadliest cancers.

Scientists have developed a three-drug treatment that completely eliminated pancreatic tumors in mice without toxic side effects. The breakthrough could transform treatment for one of the deadliest cancers, which currently has a 13% five-year survival rate.

A groundbreaking clinical trial shows that adding an antibody called NP137 to standard chemotherapy helped patients with advanced pancreatic cancer live significantly longer. The treatment worked by blocking a protein that makes tumors resistant to chemotherapy.

A Vermont hospital is pioneering a breakthrough treatment that delivers chemotherapy directly to pancreatic tumors while sparing the rest of the body from toxic side effects. The innovative approach could transform care for one of the deadliest cancers.

A groundbreaking therapy is showing real promise against cancers long considered impossible to treat, shrinking tumors in patients who'd run out of options. The experimental drug targets a genetic mutation affecting thousands of lung and pancreatic cancer patients each year.
Showing 20 of 931